Critical Care Diagnostics: Global Market Forecasts to 2023 - Microbial and Infectious Diseases Test Segment is Anticipated to Grow at the Highest CAGR - ResearchAndMarkets.com
Jun. 13, 2018
DUBLIN--(BUSINESS WIRE)--Jun 13, 2018--The "Critical Care Diagnostics - Global Market Outlook (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The Global Critical Care Diagnostics market accounted for $0.86 billion in 2016 and is expected to reach $1.34 billion by 2023 growing at a CAGR of 6.5% from 2016 to 2023.
Growing aging population and chronic health concerns, improving advancements in technologies and rapid attentiveness, increasing acceptance of these tests by physicians and patients are some of factors triggering the market growth. Furthermore, growing incidence of chronic disease such as cancer, heart disease, and diabetes are fuelling the market growth.
However, increased price of the molecular diagnostics and shortage of skilled professionals are some of the factors restraining the market growth.
Microbial and Infectious diseases test segment is anticipated to grow at the highest CAGR during the forecast period. The growth is owing to the quick and accurate test results to diagnose the disease. Immunoproteins diagnostic test segment accounted for largest market revenue due to increase massive demand for early disease diagnosis.
North America represents as the largest market in terms of revenue. High research and development activities, higher demand from U.S. boosting the North America market. Asia Pacific is projected to dominate the global market in terms of revenue due to rising specialty hospitals and convalescing healthcare services and infrastructures in rural areas.
Product TypesCancer markers testing kit Cardiometabolic monitoring kits Fecal Occult testing kits Drugs-Of-Abuse testing kits Coagulation monitoring kits Cholesterol test strips Glucose monitoring kits Pregnancy and fertility testing kits Infectious Disease testing kits Hematology testing kits Other critical care diagnostics testing kits
Test TypesHematology Coagulation Routine & Special Chemistry Microbial & Infectious Test Flow Cytometry Immunoproteins Other Test Types
Prescription ModesOTC Testing Kits Prescription-Based Testing Kits
End UsersAmbulatory surgical centers Home Hospitals Research Laboratories
Key Topics Covered
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Critical Care Diagnostics Market, By Product Type
6 Global Critical Care Diagnostics Market, By Test Type
7 Global Critical Care Diagnostics Market, By Prescription Mode
8 Global Critical Care Diagnostics Market, By End User
9 Global Critical Care Diagnostics Market, By Geography
10 Key Developments
11 Company ProfilingAbbott Laboratories Alere, Inc. Bayer Healthcare AG Beckman Coulter Becton Dickinson & Co. BioMerieux, Inc. Bio-Rad Laboratories Biosensors Japan Chembio Diagnostic Systems, Inc. EKF Diagnostics Nanomix Inc. Nova Biomedical Roche Diagnostics Ltd. Siemens Healthcare Diagnostics Sysmex Corporation
For more information about this report visit https://www.researchandmarkets.com/research/sclgs4/critical_care?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180613005790/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Diagnostics,Intensive Care and Emergency Medicine
INDUSTRY KEYWORD: PRACTICE MANAGEMENT HEALTH BIOTECHNOLOGY HOSPITALS MEDICAL DEVICES MANAGED CARE
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 06/13/2018 11:00 AM/DISC: 06/13/2018 11:01 AM